In accordance, previous studies on mouse and human hepatoma cells indicated that the activation of the VDR (Vitamin D Receptor) inhibited the expression of FXR (Farnesoid X Receptor). This evidence concerns the gene NR1H4 and hepatocellular carcinoma.